Evidence map›Paper›PMID 36941829›Full record

ArticleOpen life sciences2023

Design and functional preliminary investigation of recombinant antigen EgG1Y162-EgG1Y162 against

Yanxia Zhou, Shangqi Zhao, Yanmin Li, Mingkai Yu, Jia Zheng, Qiaoqiao Gong, Chunbao Cao, Jianbing Ding, Xiaotao Zhou

Full text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open life sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanxia ZhouDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.
Shangqi ZhaoDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.
Yanmin LiDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.
Mingkai YuDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.
Jia ZhengDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.
Qiaoqiao GongDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.
Chunbao CaoDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.
Jianbing DingDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.
Xiaotao ZhouDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Xinjiang 830011, Urumqi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the early stage, our research group cloned

Indexed as

bioinformaticsdendritic cellEchinococcus granulosusrecombinant vaccine EgG1Y162-GGGGSGGG-EgG1Y162

Identifiers

PMID36941829
PMCPMC10024343

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read27
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.